keyword
https://read.qxmd.com/read/38407385/first-don-t-be-indifferent-act-faster-if-primary-aldosteronism-is-possible
#21
EDITORIAL
Aleksander Prejbisz, Piotr Dobrowolski
No abstract text is available yet for this article.
February 26, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38404648/severe-hypercalcemia-caused-by-calcium-alkali-syndrome-after-15%C3%A2-years-of-postoperative-hypoparathyroidism-in-a-patient-with-undiagnosed-hyperaldosteronism
#22
Natália Diel Boufleuer, Dimitris V Rados, Tatiana Zambonato, Clara K Maraschin, Beatriz D Schaan
INTRODUCTION: The triad of hypercalcemia, metabolic alkalosis, and acute kidney injury associated with ingesting high doses of calcium and absorbable bases characterizes the calcium-alkali syndrome. Clinical Case . We report the case of a patient with postthyroidectomy hypoparathyroidism 15 years ago due to differentiated thyroid cancer who presented with severe hypercalcemia. He had adequate control of calcemia for many years on treatment with calcitriol and calcium carbonate and hypertension treated with amlodipine, losartan, and hydrochlorothiazide...
2024: Case Reports in Endocrinology
https://read.qxmd.com/read/38341019/chronic-activation-of-adrenal-gq-signaling-induces-cyp11b2-expression-in-the-zona-fasciculata-and-hyperaldosteronism
#23
JOURNAL ARTICLE
Desmaré van Rooyen, Antonio M Lerario, Donald W Little, Matthew R Ullenbruch, Matthew J Taylor, Celso E Gomez-Sanchez, Gary D Hammer, William E Rainey
Hyperaldosteronism is often associated with inappropriate aldosterone production and aldosterone synthase (Cyp11b2) expression. Normally, Cyp11b2 expression is limited to the adrenal zona glomerulosa (ZG) and regulated by angiotensin II which signals through Gq protein-coupled receptors. As cells migrate inwards, they differentiate into 11β-hydroxylase-expressing zona fasciculata (ZF) cells lacking Cyp11b2. The mechanism causing ZG-specific aldosterone biosynthesis is still unclear. We investigated the effect of chronic Gq signaling using transgenic mice with a clozapine N-oxide (CNO)-activated human M3 muscarinic receptor (DREADD) coupled to Gq (hM3Dq) that was expressed throughout the adrenal cortex...
February 8, 2024: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/38322542/-comparison-of-different-doses-of-acth-used-in-acth-stimulation-test-to-determine-the%C3%A2-subtypes%C3%A2-of%C3%A2-primary-aldosteronism
#24
JOURNAL ARTICLE
Ping Qiu, Li Zang, Li Zhang, Zhaohui Lyu, Yiming Mu, Qinghua Guo
OBJECTIVE: To compare the diagnostic value of adrenocorticotropic hormone (ACTH) stimulation test (AST) with different doses of ACTH combined with midnight administration of 1 mg dexamethasone for the determination of the subtypes of primary hyperaldosteronism (PA). METHODS: This is a prospective observational study. Patients diagnosed with PA in the Department of Endocrinology, the First Medical Center of of Chinese PLA General Hospital from January 1, 2020 to September 30, 2022 underwent AST with different doses of ACTH...
January 20, 2024: Sichuan da Xue Xue Bao. Yi Xue Ban, Journal of Sichuan University. Medical Science Edition
https://read.qxmd.com/read/38318706/unilateral-primary-aldosteronism-long-term-disease-recurrence-after-adrenalectomy
#25
JOURNAL ARTICLE
Martina Tetti, Denise Brüdgam, Jacopo Burrello, Aaron M Udager, Anna Riester, Thomas Knösel, Felix Beuschlein, William E Rainey, Martin Reincke, Tracy Ann Williams
BACKGROUND: Primary aldosteronism (PA) is frequently caused by a unilateral aldosterone-producing adenoma with a PA-driver mutation. Unilateral adrenalectomy has a high probability of short-term biochemical remission, but long-term postsurgical outcomes are relatively undefined. Our objective was to investigate the incidence of long-term recurrence of PA in individuals with postsurgical short-term biochemical remission. METHODS: Adrenalectomized patients for unilateral PA were included from a single referral center...
February 6, 2024: Hypertension
https://read.qxmd.com/read/38313982/moyamoya-disease-causing-stroke-in-the-setting-of-cocaine-use-and-uncontrolled-hypertension-due-to-primary-hyperaldosteronism
#26
Nathan DeRon, Francis Fischer, Tara Norris
Moyamoya disease is a cerebrovascular disease characterized by stenosis of large intracranial arteries and the development of smaller collateral vessels. Moyamoya may cause strokes and stroke-like symptoms in young patients. It has also been linked to autoimmune diseases and neuropsychiatric conditions. We present a case of moyamoya disease in a young patient with concomitant hyperaldosteronism, uncontrolled hypertension, and cocaine use disorder, along with features of antisocial personality disorder. This is a unique presentation of an underlying neurological disease causing psychiatric features exacerbated by cocaine use, and it describes a rare clinical presentation that physicians should consider in patients with moyamoya disease...
January 2024: Curēus
https://read.qxmd.com/read/38294810/dietary-sodium-alters-aldosterone-s-effect-on-renal-sodium-transporter-expression-and-distal-convoluted-tubule-remodelling
#27
JOURNAL ARTICLE
Stephanie M Mutchler, Mahpara Hasan, Carolyn P Murphy, Catherine J Baty, Cary Boyd-Shiwarski, Annet Kirabo, Thomas R Kleyman
Aldosterone is responsible for maintaining volume and potassium homeostasis. Although high salt consumption should suppress aldosterone production, individuals with hyperaldosteronism lose this regulation, leading to a state of high aldosterone despite dietary sodium consumption. The present study examines the effects of elevated aldosterone, with or without high salt consumption, on the expression of key Na+ transporters and remodelling in the distal nephron. Epithelial sodium channel (ENaC) α-subunit expression was increased with aldosterone regardless of Na+ intake...
January 31, 2024: Journal of Physiology
https://read.qxmd.com/read/38261997/healthcare-challenges-in-the-management-of-primary-aldosteronism-in-southeast-asia
#28
JOURNAL ARTICLE
Norlela Sukor, Sarat Sunthornyothin, Tran Viet Thang, Tri Juli Tarigan, Leilani B Mercado-Asis, Satha Sum, Moe Wint Aung, Alice M L Yong, Tania Tedjo, Michael Villa, Nang Ei Ei Khaing, Elena Aisha Azizan, Waye Hann Kang, Vivien Lim, Ada E D Teo, Meifen Zhang, Hieu Tran, Troy H Puar
OBJECTIVE: While guidelines have been formulated for the management of primary aldosteronism (PA), following these recommendations may be challenging in developing countries with limited healthcare access. Hence, we aimed to assess the availability and affordability of healthcare resources for managing PA in the Association of Southeast Asian Nations (ASEAN) region, which includes low-middle-income countries. DESIGN: We instituted a questionnaire-based survey to specialists managing PA, assessing the availability and affordability of investigations and treatment...
January 23, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38255973/what-we-know-about-and-what-is-new-in-primary-aldosteronism
#29
REVIEW
Natalia Ekman, Ashley B Grossman, Dorota Dworakowska
Primary aldosteronism (PA), a significant and curable cause of secondary hypertension, is seen in 5-10% of hypertensive patients, with its prevalence contingent upon the severity of the hypertension. The principal aetiologies of PA include bilateral idiopathic hypertrophy (BIH) and aldosterone-producing adenomas (APAs), while the less frequent causes include unilateral hyperplasia, familial hyperaldosteronism (FH) types I-IV, aldosterone-producing carcinoma, and ectopic aldosterone synthesis. This condition, characterised by excessive aldosterone secretion, leads to augmented sodium and water reabsorption alongside potassium loss, culminating in distinct clinical hallmarks: elevated aldosterone levels, suppressed renin levels, and hypertension...
January 11, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38234344/a-case-of-primary-aldosteronism-with-rhabdomyolysis-in-which-the-first-symptoms-were-thyrotoxicosis-and-peripheral-paralysis-and-literature-review
#30
Yunuo Zhang, Wenjuan Ni, Wei Wang
BACKGROUND: Primary aldosteronism (PA) is one of the main causes of secondary endocrine hypertension, especially refractory hypertension. Increased autonomous secretion leads to increased blood pressure and proinflammatory effects on different organ systems, including the cardiovascular system. However, because of its diverse clinical manifestations or the combination of other conditions, it sometimes causes problems for correct diagnosis. Therefore, we report and review the characteristics of some atypical and uncommon special case cases related to proaldosterone to provide clinical ideas for correct diagnosis and decision-making of proaldosterone...
2024: AME Case Reports
https://read.qxmd.com/read/38212421/adrenal-vein-sampling-does-the-location-of-the-non-adrenal-venous-sample-matter
#31
JOURNAL ARTICLE
Florian Wernig, Aleksandra Dunin-Borkowska, Angelos Frisiras, Bernard Khoo, Jeannie Todd, Aimee Di Marco, F Fausto Palazzo, Sophie C Barnes, Tricia M Tan, Karim Meeran, Ali Alsafi
PURPOSE: Adrenal vein sampling (AVS) is used to lateralise and differentiate unilateral from bilateral aldosterone production in primary aldosteronism. The adrenal venous samples are standardised to a peripheral or low inferior vena cava (IVC) sample and compared. It is unknown whether the location of the non-adrenal sample affects the results. This study compares AVS results standardised to the low IVC and right external iliac vein (REIV). METHODS: Patients who underwent AVS between March 2021 and May 2023 were included...
January 11, 2024: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/38181643/imaging-concordance-with-vein-sampling-for-primary-aldosteronism-a-cohort-study-and-literature-review
#32
JOURNAL ARTICLE
Sara Cartwright, MaKayla Gordon, Jessica Shank, Abbey Fingeret
INTRODUCTION: Adrenal venous sampling (AVS) is used to distinguish unilateral from bilateral aldosterone hypersecretion as a cause of primary aldosteronism (PA). Unilateral disease is treated with adrenalectomy and bilateral hypersecretion managed medically. METHODS: We performed a single institution retrospective cohort study of adult patients undergoing adrenalectomy for PA from July 2013 to June 2022. Concordance of imaging findings with AVS was evaluated. Statistical analysis was performed with Mann-Whitney U and chi-squared Fisher's exact...
January 4, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38175924/no-extra-adrenal-aldosterone-production-in-various-human-cell-lines
#33
JOURNAL ARTICLE
Isabelle Durrer, Daniel Ackermann, Rahel Klossner, Michael Grössl, Clarissa Vögel, Therina Du Toit, Bruno Vogt, Heidi Jamin, Markus Mohaupt, Carine Gennari-Moser
Extra-adrenal de-novo aldosterone (Aldo) production has been described inconsistently. Systematic data based upon state-of-the-art technology including validated controls are sparse. We hypothesized that aldosterone synthase (CYP11B2) expression and de-novo Aldo production are absent in non-adrenal human cell lines, either immortalized cell lines or commercially available primary cell lines, including peripheral blood mononuclear cells (PBMCs) of individuals without and with primary hyperaldosteronism (PA)...
January 1, 2024: Journal of Molecular Endocrinology
https://read.qxmd.com/read/38164017/effect-of-mild-cortisol-cosecretion-on-body-composition-and-metabolic-parameters-in-patients-with-primary-hyperaldosteronism
#34
JOURNAL ARTICLE
Nabeel Mansour, Denise Bruedgam, Ulrich Dischinger, Lydia Kürzinger, Christian Adolf, Roman Walter, Osman Öcal, Vanessa F Schmidt, Jan Rudolph, Jens Ricke, Nicole Reisch, Martin Reincke, Moritz Wildgruber, Daniel Heinrich
OBJECTIVE: To investigate the effects of simultaneous cortisol cosecretion (CCS) on body composition in computed tomography (CT)-imaging and metabolic parameters in patients with primary aldosteronism (PA) with the objective of facilitating early detection. DESIGN: Retrospective cohort study. PATIENTS: Forty-seven patients with PA and CCS confirmed by 1-mg dexamethasone suppression test (DST) with a cutoff of ≥1.8 µg/dL were compared with PA patients with excluded CCS (non-CCS, n = 47) matched by age and sex...
January 1, 2024: Clinical Endocrinology
https://read.qxmd.com/read/38162054/-metabolic-outcomes-of-primary-aldosteronism-patients-receiving-adrenalectomy-or-spironolactone-treatments
#35
JOURNAL ARTICLE
Chenxiao Xu, Tao Chen, Dan Mo, Tingting Zhang, Fangli Zhou, Haoming Tian, Yan Ren
OBJECTIVE: To investigate the metabolic outcomes of primary aldosteronism (PA) patients receiving adrenalectomy (ADX) or spironolactone treatment and the contributing factors to the metabolic outcomes. METHODS: The clinical data of 70 patients with aldosterone-producing adenoma (APA) and 86 patients with idiopathic hyperaldosteronism (IHA) were retrospectively analyzed. All subjects received confirmatory diagnosis of APA or IHA at the Department of Endocrinology and Metabolism, West China Hospital between March 2018 and October 2020...
November 20, 2023: Sichuan da Xue Xue Bao. Yi Xue Ban, Journal of Sichuan University. Medical Science Edition
https://read.qxmd.com/read/38134306/prolonged-hypokalemia-and-delayed-diagnosis-of-primary-aldosteronism-clinical-course-and-risk-factors
#36
JOURNAL ARTICLE
Gaytri Gupta, Ada E D Teo, Du Soon Swee, Lih Ming Loh, Matthew Chuah, Wann Jia Loh, Seyed Ehsan Saffari, Xuan Han Koh, Peng Chin Kek, Troy H Puar
INTRODUCTION: Primary Aldosteronism (PA) is a common cause of hypertension. However, diagnosis is often delayed, leading to poorer clinical outcomes. Hypokalemia with hypertension is characteristic of PA, and is an indication for screening. We evaluated if patients with PA had prolonged hypokalemia before diagnosis, the subsequent biochemical/clinical control, and factors associated with delayed diagnosis. METHODS: Our study included all PA patients with hypokalemia diagnosed between 2001 to 2022...
December 22, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38127970/correlation-of-histopathologic-subtypes-of-primary-aldosteronism-with-clinical-phenotypes-and-postsurgical-outcomes
#37
JOURNAL ARTICLE
Chang Ho Ahn, You-Bin Lee, Jae Hyeon Kim, Young Lyun Oh, Jung Hee Kim, Kyeong Cheon Jung
CONTEXT: Clinical implications of unilateral primary aldosteronism (PA) histopathology remain to be determined in various ethnic populations. OBJECTIVE: We examined the histopathology of unilateral PA using CYP11B2 immunostaining in relation to clinical phenotypes and postsurgical outcomes. METHODS: Patients consecutively operated for unilateral PA from 2010 to 2020 at three tertiary hospitals in South Korea were retrospectively enrolled. Adrenals with solitary aldosterone-producing adenomas and/or dominant aldosterone-producing nodules were classified as the classical and the others as the nonclassical groups...
December 21, 2023: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38123759/water-and-electrolyte-content-in-salt-dependent-hypertension-in-the-skin-whyski-effect-of-surgical-cure-of-primary-aldosteronism
#38
JOURNAL ARTICLE
Francesca Torresan, Federico Bernardo Rossi, Sofia Zanin, Ilaria Caputo, Brasilina Caroccia, Maurizio Iacobone, Gian Paolo Rossi
UNLABELLED:  INTRODUCTION: This study will test the hypothesis that primary aldosteronism (PA) involves alterations in Na+ , K+ , and water content in the skin that are corrected by adrenalectomy. AIM AND METHODS: In skin biopsies, we will measure the content of Na+ , K+ , water, by physical-chemical methods and the osmotic-stress-responsive transcription factor Tonicity-responsive Enhancer Binding Protein (TonEBP, NFAT5) mRNA copy number by droplet digital PCR, in sex-balanced cohorts of 18 -75-year-old consecutive consenting patients with unilateral and bilateral PA, primary (essential) hypertension, and normotension...
December 21, 2023: High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension
https://read.qxmd.com/read/38108666/beyond-the-three-p-s-adrenal-involvement-in-men1
#39
JOURNAL ARTICLE
Uriel Clemente-Gutierrez, Carolina R C Pieterman, Michael S Lui, Thomas Szabo Yamashita, Andrés Tame-Elorduy, Bernice L Huang, Aditya S Shirali, Derek J Erstad, Jeffrey E Lee, Sarah B Fisher, Paul H Graham, Elizabeth G Grubbs, Steven G Waguespack, Chaan S Ng, Nancy Perrier
Adrenal lesions (ALs) are often detected in patients with multiple endocrine neoplasia type 1 (MEN1). However, they are not well described in MEN1, making their clinical management unclear. This study examined the prevalence and outcomes of ALs found in MEN1. We performed a retrospective chart review of patients diagnosed with MEN1 from 1990 to 2021. ALs were diagnosed using abdominal or thoracic imaging and classified as being unilateral or bilateral, having single or multiple nodules, and as having diffuse enlargement or not...
February 1, 2024: Endocrine-related Cancer
https://read.qxmd.com/read/38095087/diagnostic-delay-and-disease-burden-in-primary-aldosteronism-an-international-patient-survey
#40
JOURNAL ARTICLE
Roshan A Ananda, Stella May Gwini, Katrina M Long, Jordan H Lai, Gang Chen, Grant M Russell, Michael Stowasser, Peter J Fuller, Jun Yang
BACKGROUND: Primary aldosteronism (PA) is a common but underdiagnosed cause of hypertension. Many patients experience preventable end-organ injury due to delayed or missed diagnosis but data on the experience of patients are limited. METHODS: We evaluated the lived experience of PA and determines factors associated with diagnostic delay through an international anonymous online cross-sectional survey, codesigned by researchers and PA consumers. We distributed the survey through academic medical centers, Amazon Mechanical Turk, Twitter, PA patient advocacy groups, and hypertension support groups on Facebook between March 21 and June 5, 2022...
December 14, 2023: Hypertension
keyword
keyword
3023
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.